Le Lézard
Classified in: Business
Subject: ATY

VTYX Investors Have Opportunity to Lead Ventyx Biosciences, Inc. Securities Fraud Lawsuit


BENSALEM, Pa., April 16, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX).

Class Period: October 21, 2021 ? November 6, 2023

Lead Plaintiff Deadline: April 30, 2024

Investors suffering losses on their Ventyx investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 215-638-4847 or by email to [email protected].

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors that: (1) VTX958 was less effective in treating psoriasis than Defendants had led investors to believe; (2) as a result, VTX958's clinical and/or commercial prospects were overstated; (3) accordingly, the Company had misrepresented its ability to develop and commercialize effective product candidates; (4) Ventyx's post-IPO business prospects were thus inflated; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847 or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
[email protected]
www.howardsmithlaw.com

SOURCE Law Offices of Howard G. Smith


These press releases may also interest you

at 11:50
Regulatory News: Teleperformance (Paris:TEP), a global leader in digital business services, today released its quarterly revenue figures for the three months ended March 31, 2024. First-quarter 2024 revenue ?2,542 million A new expanded...

at 11:45
Graphene Manufacturing Group Ltd. ("GMG" or the "Company") is pleased to announce that, further to its news releases dated April 26, 2024 and April 25, 2024, due to higher demand, the Company and PI Financial Corp. as sole underwriter and...

at 11:44
Dividend Announcement: On 30 April 2024, the Board of Directors of Tetragon declared a dividend of U.S.$ 0.11 (11.00 cents) per share in respect of the first quarter of 2024. The ex-dividend date is 2 May 2024. The record date is 3 May 2024. Payment...

at 11:41
The following issues have been halted by CIRO: Company: THREE SIXTY SOLAR LTD. NEO Exchange Symbol : VSOL All Issues: Yes Reason: Pending News Halt Time (ET): 11:29 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a...

at 11:41
Frontenac Mortgage Investment Corporation ("FMIC") announces that it has filed audited annual financial statements and related management's discussion and analysis ("MD&A") for the year ended December 31, 2023 (the "2023 Audited Annual Financial...

at 11:41
Tetragon has released its Monthly Factsheet for March 2024. - Net Asset Value: $ 2,830m- Fully Diluted NAV Per Share: $31.05- Share Price (TFG NA): $9.88- Monthly NAV per share total return: 0.7%- Monthly Return on Equity: 1.2%- Most recent quarterly...



News published on and distributed by: